APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pemirolast

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pemirolast Industry Growth and Trends Forecast to 2032

31 December 2025101 pages

Choose your research edition.

Industry ResearchPemirolast Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemirolast Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pemirolast Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemirolast Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemirolast Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pemirolast market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pemirolast is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pemirolast is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pemirolast is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pemirolast include SAMYANG CHEMICAL, SanTen, Vegesna Laboratories, Toronto Research Chemicals, LGM Pharma, Jiaxing Epochem Pharmtech, FEIMA YAOYE, Clearsynth and ChemScence, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pemirolast market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pemirolast market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pemirolast market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pemirolast.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pemirolast market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pemirolast Market by Company

SAMYANG CHEMICAL

SanTen

Vegesna Laboratories

Toronto Research Chemicals

LGM Pharma

Jiaxing Epochem Pharmtech

FEIMA YAOYE

Clearsynth

ChemScence

AESCU PHARMA

Pemirolast Segment by Type

Drop

Tablet

Other

Pemirolast Segment by Application

Eye Disease

Asthma

Other

Pemirolast Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemirolast market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemirolast and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemirolast.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pemirolast manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pemirolast in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Drop Table 2. Major Company of Tablet Table 3. Major Company of Other Table 4. Global Pemirolast Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pemirolast Sales by Type (2021-2026) & (K Units) Table 6. Global Pemirolast Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pemirolast Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pemirolast Sales Market Share in Value by Type (2021-2026) Table 9. Global Pemirolast Price by Type (2021-2026) & (US$/Unit) Table 10. Global Pemirolast Sales by Type (2027-2032) & (K Units) Table 11. Global Pemirolast Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pemirolast Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pemirolast Sales Market Share in Value by Type (2027-2032) Table 14. Global Pemirolast Price by Type (2027-2032) & (US$/Unit) Table 15. North America Pemirolast Sales by Type (2021-2026) & (K Units) Table 16. North America Pemirolast Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pemirolast Sales by Type (2021-2026) & (K Units) Table 18. Europe Pemirolast Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pemirolast Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Pemirolast Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pemirolast Sales by Type (2021-2026) & (K Units) Table 22. Latin America Pemirolast Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pemirolast Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Pemirolast Sales by Type (2021-2026) & (US$ Million) Table 25. Pemirolast Industry Trends Table 26. Pemirolast Industry Drivers Table 27. Pemirolast Industry Opportunities and Challenges Table 28. Pemirolast Industry Restraints Table 29. Global Pemirolast Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pemirolast Revenue Market Share by Company (2021-2026) Table 31. Global Pemirolast Sales by Company (2021-2026) & (K Units) Table 32. Global Pemirolast Sales Share by Company (2021-2026) Table 33. Global Pemirolast Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Pemirolast Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pemirolast Major Company Production Sites and Headquarters Table 36. Global Pemirolast Company, Product Type & Application Table 37. Global Pemirolast Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pemirolast by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pemirolast Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pemirolast Sales by Region (2021-2026) & (K Units) Table 42. Global Pemirolast Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pemirolast Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pemirolast Sales Market Share in Value by Region (2021-2026) Table 45. Global Pemirolast Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Pemirolast Sales by Region (2027-2032) & (K Units) Table 47. Global Pemirolast Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pemirolast Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pemirolast Sales Market Share in Value by Region (2027-2032) Table 50. Global Pemirolast Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Pemirolast Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pemirolast Sales by Application (2021-2026) & (K Units) Table 53. Global Pemirolast Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pemirolast Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pemirolast Sales Market Share in Value by Application (2021-2026) Table 56. Global Pemirolast Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pemirolast Sales by Application (2027-2032) & (K Units) Table 58. Global Pemirolast Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pemirolast Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pemirolast Sales Market Share in Value by Application (2027-2032) Table 61. Global Pemirolast Price by Application (2027-2032) & (US$/Unit) Table 62. North America Pemirolast Sales by Application (2021-2026) & (K Units) Table 63. North America Pemirolast Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pemirolast Sales by Application (2021-2026) & (K Units) Table 65. Europe Pemirolast Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pemirolast Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Pemirolast Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pemirolast Sales by Application (2021-2026) & (K Units) Table 69. Latin America Pemirolast Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pemirolast Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Pemirolast Sales by Application (2021-2026) & (US$ Million) Table 72. SAMYANG CHEMICAL Company Information Table 73. SAMYANG CHEMICAL Business Overview Table 74. SAMYANG CHEMICAL Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. SAMYANG CHEMICAL Pemirolast Product Portfolio Table 76. SAMYANG CHEMICAL Recent Development Table 77. SanTen Company Information Table 78. SanTen Business Overview Table 79. SanTen Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. SanTen Pemirolast Product Portfolio Table 81. SanTen Recent Development Table 82. Vegesna Laboratories Company Information Table 83. Vegesna Laboratories Business Overview Table 84. Vegesna Laboratories Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Vegesna Laboratories Pemirolast Product Portfolio Table 86. Vegesna Laboratories Recent Development Table 87. Toronto Research Chemicals Company Information Table 88. Toronto Research Chemicals Business Overview Table 89. Toronto Research Chemicals Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Toronto Research Chemicals Pemirolast Product Portfolio Table 91. Toronto Research Chemicals Recent Development Table 92. LGM Pharma Company Information Table 93. LGM Pharma Business Overview Table 94. LGM Pharma Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. LGM Pharma Pemirolast Product Portfolio Table 96. LGM Pharma Recent Development Table 97. Jiaxing Epochem Pharmtech Company Information Table 98. Jiaxing Epochem Pharmtech Business Overview Table 99. Jiaxing Epochem Pharmtech Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Jiaxing Epochem Pharmtech Pemirolast Product Portfolio Table 101. Jiaxing Epochem Pharmtech Recent Development Table 102. FEIMA YAOYE Company Information Table 103. FEIMA YAOYE Business Overview Table 104. FEIMA YAOYE Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. FEIMA YAOYE Pemirolast Product Portfolio Table 106. FEIMA YAOYE Recent Development Table 107. Clearsynth Company Information Table 108. Clearsynth Business Overview Table 109. Clearsynth Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Clearsynth Pemirolast Product Portfolio Table 111. Clearsynth Recent Development Table 112. ChemScence Company Information Table 113. ChemScence Business Overview Table 114. ChemScence Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. ChemScence Pemirolast Product Portfolio Table 116. ChemScence Recent Development Table 117. AESCU PHARMA Company Information Table 118. AESCU PHARMA Business Overview Table 119. AESCU PHARMA Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. AESCU PHARMA Pemirolast Product Portfolio Table 121. AESCU PHARMA Recent Development Table 122. North America Pemirolast Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Pemirolast Sales by Country (2021-2026) & (K Units) Table 124. North America Pemirolast Sales Market Share by Country (2021-2026) Table 125. North America Pemirolast Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Pemirolast Sales Market Share Forecast by Country (2027-2032) Table 127. North America Pemirolast Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Pemirolast Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Pemirolast Market Share by Country (2021-2026) Table 130. North America Pemirolast Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Pemirolast Market Share Forecast by Country (2027-2032) Table 132. Europe Pemirolast Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Pemirolast Sales by Country (2021-2026) & (K Units) Table 134. Europe Pemirolast Sales Market Share by Country (2021-2026) Table 135. Europe Pemirolast Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Pemirolast Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Pemirolast Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Pemirolast Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Pemirolast Market Share by Country (2021-2026) Table 140. Europe Pemirolast Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Pemirolast Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Pemirolast Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Pemirolast Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Pemirolast Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Pemirolast Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Pemirolast Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Pemirolast Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Pemirolast Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Pemirolast Market Share by Country (2021-2026) Table 150. Asia-Pacific Pemirolast Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Pemirolast Market Share Forecast by Country (2027-2032) Table 152. Latin America Pemirolast Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Pemirolast Sales by Country (2021-2026) & (K Units) Table 154. Latin America Pemirolast Sales Market Share by Country (2021-2026) Table 155. Latin America Pemirolast Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Pemirolast Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Pemirolast Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Pemirolast Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Pemirolast Market Share by Country (2021-2026) Table 160. Latin America Pemirolast Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Pemirolast Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Pemirolast Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Pemirolast Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Pemirolast Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Pemirolast Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Pemirolast Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Pemirolast Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Pemirolast Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Pemirolast Market Share by Country (2021-2026) Table 170. Middle East and Africa Pemirolast Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Pemirolast Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Pemirolast Distributors List Table 175. Pemirolast Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Pemirolast Image Figure 2. Global Pemirolast Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemirolast Market Size (2021-2032) & (US$ Million) Figure 4. Global Pemirolast Sales (2021-2032) & (K Units) Figure 5. Drop Image Figure 6. Global Drop Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Pemirolast Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pemirolast Market Share by Type 2025 VS 2032 Figure 13. North America Pemirolast Sales Market Share in Volume by Type in 2025 Figure 14. North America Pemirolast Sales Market Share in Value by Type in 2025 Figure 15. Europe Pemirolast Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pemirolast Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pemirolast Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pemirolast Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pemirolast Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pemirolast Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pemirolast Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pemirolast Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pemirolast Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Eye Disease Image Figure 26. Global Eye Disease Sales YoY Growth (2021-2032) & (K Units) Figure 27. Asthma Image Figure 28. Global Asthma Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Pemirolast Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pemirolast Market Share by Application 2025 VS 2032 Figure 33. North America Pemirolast Sales Market Share in Volume by Application in 2025 Figure 34. North America Pemirolast Sales Market Share in Value by Application in 2025 Figure 35. Europe Pemirolast Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pemirolast Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pemirolast Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pemirolast Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pemirolast Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pemirolast Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pemirolast Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pemirolast Sales Market Share in Value by Application in 2025 Figure 43. North America Pemirolast Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Pemirolast Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pemirolast Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pemirolast Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pemirolast Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Pemirolast Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pemirolast Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pemirolast Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pemirolast Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Pemirolast Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pemirolast Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pemirolast Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pemirolast Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Pemirolast Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pemirolast Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pemirolast Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pemirolast Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Pemirolast Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pemirolast Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pemirolast Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pemirolast Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pemirolast Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Drop
  • Tablet
  • Other
Applications
  • Eye Disease
  • Asthma
  • Other
Companies covered
  • SAMYANG CHEMICAL
  • SanTen
  • Vegesna Laboratories
  • Toronto Research Chemicals
  • LGM Pharma
  • Jiaxing Epochem Pharmtech
  • FEIMA YAOYE
  • Clearsynth
  • ChemScence
  • AESCU PHARMA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pemirolast Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pemirolast Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pemirolast Market by Type
  6. 1.3.1 Drop
  7. 1.3.2 Tablet
  8. 1.3.3 Other
  9. 1.4 Global Pemirolast Market Size by Type
  10. 1.4.1 Global Pemirolast Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pemirolast Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pemirolast Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pemirolast Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pemirolast Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pemirolast Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pemirolast Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pemirolast Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pemirolast Industry Trends
  2. 2.2 Pemirolast Industry Drivers
  3. 2.3 Pemirolast Industry Opportunities and Challenges
  4. 2.4 Pemirolast Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pemirolast Revenue (2021-2026)
  2. 3.2 Global Top Players by Pemirolast Sales (2021-2026)
  3. 3.3 Global Top Players by Pemirolast Price (2021-2026)
  4. 3.4 Global Pemirolast Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pemirolast Major Company Production Sites & Headquarters
  6. 3.6 Global Pemirolast Company, Product Type & Application
  7. 3.7 Global Pemirolast Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pemirolast Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pemirolast Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pemirolast Tier 1, Tier 2, and Tier 3
4 Pemirolast Regional Status and Outlook
  1. 4.1 Global Pemirolast Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pemirolast Historic Market Size by Region
  3. 4.2.1 Global Pemirolast Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pemirolast Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pemirolast Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pemirolast Forecasted Market Size by Region
  7. 4.3.1 Global Pemirolast Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pemirolast Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pemirolast Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pemirolast by Application
  1. 5.1 Pemirolast Market by Application
  2. 5.1.1 Eye Disease
  3. 5.1.2 Asthma
  4. 5.1.3 Other
  5. 5.2 Global Pemirolast Market Size by Application
  6. 5.2.1 Global Pemirolast Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pemirolast Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pemirolast Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pemirolast Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pemirolast Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pemirolast Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pemirolast Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pemirolast Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 SAMYANG CHEMICAL
  2. 6.1.1 SAMYANG CHEMICAL Company Information
  3. 6.1.2 SAMYANG CHEMICAL Business Overview
  4. 6.1.3 SAMYANG CHEMICAL Pemirolast Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 SAMYANG CHEMICAL Pemirolast Product Portfolio
  6. 6.1.5 SAMYANG CHEMICAL Recent Developments
  7. 6.2 SanTen
  8. 6.2.1 SanTen Company Information
  9. 6.2.2 SanTen Business Overview
  10. 6.2.3 SanTen Pemirolast Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SanTen Pemirolast Product Portfolio
  12. 6.2.5 SanTen Recent Developments
  13. 6.3 Vegesna Laboratories
  14. 6.3.1 Vegesna Laboratories Company Information
  15. 6.3.2 Vegesna Laboratories Business Overview
  16. 6.3.3 Vegesna Laboratories Pemirolast Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Vegesna Laboratories Pemirolast Product Portfolio
  18. 6.3.5 Vegesna Laboratories Recent Developments
  19. 6.4 Toronto Research Chemicals
  20. 6.4.1 Toronto Research Chemicals Company Information
  21. 6.4.2 Toronto Research Chemicals Business Overview
  22. 6.4.3 Toronto Research Chemicals Pemirolast Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Toronto Research Chemicals Pemirolast Product Portfolio
  24. 6.4.5 Toronto Research Chemicals Recent Developments
  25. 6.5 LGM Pharma
  26. 6.5.1 LGM Pharma Company Information
  27. 6.5.2 LGM Pharma Business Overview
  28. 6.5.3 LGM Pharma Pemirolast Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 LGM Pharma Pemirolast Product Portfolio
  30. 6.5.5 LGM Pharma Recent Developments
  31. 6.6 Jiaxing Epochem Pharmtech
  32. 6.6.1 Jiaxing Epochem Pharmtech Company Information
  33. 6.6.2 Jiaxing Epochem Pharmtech Business Overview
  34. 6.6.3 Jiaxing Epochem Pharmtech Pemirolast Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiaxing Epochem Pharmtech Pemirolast Product Portfolio
  36. 6.6.5 Jiaxing Epochem Pharmtech Recent Developments
  37. 6.7 FEIMA YAOYE
  38. 6.7.1 FEIMA YAOYE Company Information
  39. 6.7.2 FEIMA YAOYE Business Overview
  40. 6.7.3 FEIMA YAOYE Pemirolast Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 FEIMA YAOYE Pemirolast Product Portfolio
  42. 6.7.5 FEIMA YAOYE Recent Developments
  43. 6.8 Clearsynth
  44. 6.8.1 Clearsynth Company Information
  45. 6.8.2 Clearsynth Business Overview
  46. 6.8.3 Clearsynth Pemirolast Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Clearsynth Pemirolast Product Portfolio
  48. 6.8.5 Clearsynth Recent Developments
  49. 6.9 ChemScence
  50. 6.9.1 ChemScence Company Information
  51. 6.9.2 ChemScence Business Overview
  52. 6.9.3 ChemScence Pemirolast Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ChemScence Pemirolast Product Portfolio
  54. 6.9.5 ChemScence Recent Developments
  55. 6.10 AESCU PHARMA
  56. 6.10.1 AESCU PHARMA Company Information
  57. 6.10.2 AESCU PHARMA Business Overview
  58. 6.10.3 AESCU PHARMA Pemirolast Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AESCU PHARMA Pemirolast Product Portfolio
  60. 6.10.5 AESCU PHARMA Recent Developments
7 North America by Country
  1. 7.1 North America Pemirolast Sales by Country
  2. 7.1.1 North America Pemirolast Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pemirolast Sales by Country (2021-2026)
  4. 7.1.3 North America Pemirolast Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pemirolast Market Size by Country
  6. 7.2.1 North America Pemirolast Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pemirolast Market Size by Country (2021-2026)
  8. 7.2.3 North America Pemirolast Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pemirolast Sales by Country
  2. 8.1.1 Europe Pemirolast Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pemirolast Sales by Country (2021-2026)
  4. 8.1.3 Europe Pemirolast Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pemirolast Market Size by Country
  6. 8.2.1 Europe Pemirolast Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pemirolast Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pemirolast Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pemirolast Sales by Country
  2. 9.1.1 Asia-Pacific Pemirolast Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pemirolast Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pemirolast Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pemirolast Market Size by Country
  6. 9.2.1 Asia-Pacific Pemirolast Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pemirolast Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pemirolast Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pemirolast Sales by Country
  2. 10.1.1 South America Pemirolast Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pemirolast Sales by Country (2021-2026)
  4. 10.1.3 South America Pemirolast Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pemirolast Market Size by Country
  6. 10.2.1 South America Pemirolast Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pemirolast Market Size by Country (2021-2026)
  8. 10.2.3 South America Pemirolast Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pemirolast Sales by Country
  2. 11.1.1 Middle East and Africa Pemirolast Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pemirolast Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pemirolast Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pemirolast Market Size by Country
  6. 11.2.1 Middle East and Africa Pemirolast Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pemirolast Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pemirolast Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pemirolast Value Chain Analysis
  2. 12.1.1 Pemirolast Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pemirolast Production Mode & Process
  7. 12.2 Pemirolast Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pemirolast Distributors
  10. 12.2.3 Pemirolast Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst